-
Glp-1 medications like semaglutide (Ozempic, Wegovy)) and Tirzepatide (Mounjaro, Zepbound) are designed for long-term use to treat chronic disease/conditions. What happens if people go on and off them?
Medical Mythbusting Commentary for October 30, 2026 Source:Everyone’s going on — and off — GLP-1s. What’s that doing to your health?
-
Wegovy (semaglutide) now approved by Health Canada to reduce the risk of non-fatal heart attack in people with known cardiovascular disease in addition to its use for weight loss management.
Medical Mythbusting Commentary for November 28, 2024 Source:Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
-
Biggest Loser producer’s comments exemplify fat-shaming attitude so destructive to people with obesity
Health Headlines Commentary for June 12, 2017 Source: ‘Biggest Loser’ producer says ex-contestants to blame for regaining weight